MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-KL-10-0007940
Larimar Pharmaceuticals Private Limited
Larimar Pharmaceuticals Private Limited - home appliances in Chennai, Tamil Nadu, India. Directors, charges & compliance details.
Revenue · FY 2025
₹2.18 Cr
▲ 2% YoY
Net profit · FY 2025
₹4.23 Lakh
Net margin 1.9%
EBITDA · FY 2025
₹9.87 Lakh
EBITDA margin 4.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹20,000
Issued & subscribed
Open charges
₹8 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
About Larimar Pharmaceuticals Private Limited
Data last updated:
Larimar Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the household goods segment of the home appliances and consumer durables sector. It was incorporated on 28 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51397TN2021PTC143154.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹20,000. It is led by directors including Mariappan Shollamuthu (Managing Director) and Arun.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 7 Vijayalakshmi Nagar Ariyur, Chennai, Tamil Nadu, India – 605102.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.18 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹4.23 Lakh (net margin 1.9%) and EBITDA of ₹9.87 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 352% over three years.
As per MCA filings, the company has open charges of ₹8 Lakh on record.
Larimar Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-10-0007940).
Company details
CIN U51397TN2021PTC143154
Registration Number 143154
Incorporation Date 28 April 2021
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-KL-10-0007940
Key People
Mariappan Shollamuthu Managing Director Arun Director Manickam Kavilpad Manikandan Additional Director Recognitions & Rankings of Larimar Pharmaceuticals
Contact details
Larimar Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered Address7 Vijayalakshmi Nagar Ariyur, Chennai, Tamil Nadu, India – 605102
- IndustryHome Appliances, Household Goods, Wholesale
Comprehensive company report
Larimar Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Larimar Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Larimar Pharmaceuticals Private Limited, buy the company report.
Financials of Larimar Pharmaceuticals Private Limited
FY 2025 filings availableLarimar Pharmaceuticals Private Limited reported revenue of ₹2.18 Cr (up 2% YoY) for FY 2025.
Revenue · FY 2025
₹2.18 Cr ▲ 2%
Net profit · FY 2025
₹4.23 Lakh margin 1.9%
EBITDA · FY 2025
₹9.87 Lakh margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 352%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 69%
Revenue has grown at a compounded annual rate (CAGR) of 352% over three years, including 2% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹9.87 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹4.23 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.5% | |||
| Net Profit Margin | 1.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Larimar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Larimar Pharmaceuticals Private Limited
Larimar Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mariappan Shollamuthu | Managing Director | 28 Apr 2021 | 5 Years 6 Months | Current |
| Arun | Director | 28 Apr 2021 | 5 Years 6 Months | Current |
| Manickam Kavilpad Manikandan | Additional Director | 17 Sep 2024 | 2 Years 1 Months | Current |
Charges & borrowings
Open charges
₹8 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jan 2023 | 100679024 | Indian Overseas Bank | ₹8 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Larimar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Larimar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Larimar Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Larimar Pharmaceuticals Private Limited has 5 board changes on record since 2021: 3 appointments and 2 cessations. The latest: Manickam Kavilpad Manikandan was appointed as Additional Director on 17 Sep 2024.
AGM
Larimar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Larimar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Manickam Kavilpad Manikandan was appointed as Additional Director.
Ceased
Mariappan Shollamuthu ceased to be Director.
Charges
A charge with Indian Overseas Bank amounted to Rs. 8.00 Lakh with Charge ID 100679024 was registered on 09 Jan 2023.
Ceased
Velu Selvaraj Nisanth ceased to be Additional Director.
Appointed
Arun was appointed as Director.
Appointed
Mariappan Shollamuthu was appointed as Managing Director.
Incorporation
28 Apr 2021
Larimar Pharmaceuticals Private Limited was registered on 28 Apr 2021 with Roc Chennai & aged 5 years 6 months as per MCA records.
Frequently asked questions
Larimar Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in household goods, within the home appliances industry. It was incorporated on 28 April 2021 (5+ years old) and is registered under CIN U51397TN2021PTC143154.
Larimar Pharmaceuticals has 3 current directors:
- Mariappan Shollamuthu - Managing Director
- Arun - Director
- Manickam Kavilpad Manikandan - Additional Director
The latest financial statements of Larimar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Larimar Pharmaceuticals is U51397TN2021PTC143154. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Larimar Pharmaceuticals was incorporated on 28 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
Manickam Kavilpad Manikandan was appointed as Additional Director on 17 Sep 2024. Mariappan Shollamuthu ceased to be Director on 01 Mar 2023. Velu Selvaraj Nisanth ceased to be Additional Director on 23 Aug 2022. Larimar Pharmaceuticals has 5 board changes on record in total.
Yes, Larimar Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-10-0007940).
The registered office of Larimar Pharmaceuticals is at 7 Vijayalakshmi Nagar Ariyur, Chennai, Tamil Nadu, India – 605102.
Larimar Pharmaceuticals operates in the home appliances industry, in the household goods segment.
Larimar Pharmaceuticals has open charges of ₹8 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages